| Followers | 605 |
| Posts | 69362 |
| Boards Moderated | 1 |
| Alias Born | 01/09/2007 |
Monday, September 28, 2015 12:41:47 PM
A strong buy for the WOCKET!
NXT-ID Receives Consensus Rating of “Strong Buy” from Analysts (NASDAQ:NXTD)
Christopher T. Ellis
Sept. 27, 2015
NXT-ID (NASDAQ:NXTD) has received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.
Brokerages have set a one year consensus price target of $5.75 for the company and are expecting that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also assigned NXT-ID an industry rank of 95 out of 265 based on the ratings given to related companies.
Several research firms have weighed in on NXTD. Northland Securities decreased their price objective on shares of NXT-ID from $6.00 to $5.75 and set an “outperform” rating on the stock in a report on Thursday, June 4th. Zacks raised shares of NXT-ID from a “sell” rating to a “hold” rating in a research note on Monday, August 17th. Finally, Benchmark Co. reissued a “” rating and issued a $6.00 price objective on shares of NXT-ID in a research report on Wednesday.
NXT-ID (NASDAQ:NXTD) opened at 0.9787 on Thursday. The company has a 50 day moving average of $1.16 and a 200-day moving average of $2.19. NXT-ID has a one year low of $0.79 and a one year high of $4.20. The company’s market cap is $26.95 million.
http://i.ytimg.com/vi/8HXGSAR6CYA/maxresdefault.jpg
NXT-ID Inc is a United States-based company that provides security solutions to mobile devices. The Company provides MobileBio, a suite of biometric solutions that secure consumers’ mobile platforms with focus on the growing m-commerce market. MobileBio mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The Company’s products are MobileBio biocloud; identity authentication solution for consumer applications, MobileBio wocket, MobileBio facematch; facial recognition system for smartphones, tablets, laptop and desktop, and MobileBio voicematch; identification of the specific individual and can communicate with the intended device directly or remotely.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
NXT-ID Receives Consensus Rating of “Strong Buy” from Analysts (NASDAQ:NXTD)
Christopher T. Ellis
Sept. 27, 2015
NXT-ID (NASDAQ:NXTD) has received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.
Brokerages have set a one year consensus price target of $5.75 for the company and are expecting that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also assigned NXT-ID an industry rank of 95 out of 265 based on the ratings given to related companies.
Several research firms have weighed in on NXTD. Northland Securities decreased their price objective on shares of NXT-ID from $6.00 to $5.75 and set an “outperform” rating on the stock in a report on Thursday, June 4th. Zacks raised shares of NXT-ID from a “sell” rating to a “hold” rating in a research note on Monday, August 17th. Finally, Benchmark Co. reissued a “” rating and issued a $6.00 price objective on shares of NXT-ID in a research report on Wednesday.
NXT-ID (NASDAQ:NXTD) opened at 0.9787 on Thursday. The company has a 50 day moving average of $1.16 and a 200-day moving average of $2.19. NXT-ID has a one year low of $0.79 and a one year high of $4.20. The company’s market cap is $26.95 million.
http://i.ytimg.com/vi/8HXGSAR6CYA/maxresdefault.jpg
NXT-ID Inc is a United States-based company that provides security solutions to mobile devices. The Company provides MobileBio, a suite of biometric solutions that secure consumers’ mobile platforms with focus on the growing m-commerce market. MobileBio mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The Company’s products are MobileBio biocloud; identity authentication solution for consumer applications, MobileBio wocket, MobileBio facematch; facial recognition system for smartphones, tablets, laptop and desktop, and MobileBio voicematch; identification of the specific individual and can communicate with the intended device directly or remotely.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
